批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2016/10/12 |
ORIG-2(原始申请) |
Approval |
|
|
|
|
| 2012/10/15 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2023/08/25 |
SUPPL-30(补充) |
Approval |
Labeling-Container/Carton Labels,Labeling-Package Insert |
STANDARD
|
|
|
| 2023/08/25 |
SUPPL-28(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2021/06/04 |
SUPPL-26(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2021/06/04 |
SUPPL-23(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2019/04/25 |
SUPPL-13(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2019/04/25 |
SUPPL-8(补充) |
Approval |
Labeling-Package Insert,Labeling-Container/Carton Labels |
STANDARD
|
|
|
| 2013/08/29 |
SUPPL-1(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
| 无 |
与本品治疗等效的药品
>>>活性成分:HYDROCHLOROTHIAZIDE; IRBESARTAN; 剂型/给药途径:TABLET;ORAL; 规格:12.5MG;150MG; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 020758 |
002 |
NDA |
AVALIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
Yes |
Yes |
AB |
1997/09/30
|
SANOFI AVENTIS US |
| 077369 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/03/30
|
TEVA |
| 077446 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/09/27
|
SANDOZ |
| 202414 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/09/27
|
MACLEODS PHARMS LTD |
| 203500 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/09/27
|
DR REDDYS LABS LTD |
| 090351 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/10/15
|
HIKMA |
| 091370 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/10/15
|
ALEMBIC |
| 203630 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2013/02/22
|
AUROBINDO PHARMA LTD |
| 201524 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Discontinued |
No |
No |
AB |
2013/02/27
|
LUPIN LTD |
| 203072 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2014/05/09
|
PRINSTON INC |
| 207896 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2016/10/14
|
HISUN PHARM HANGZHOU |
| 207018 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Discontinued |
No |
No |
AB |
2017/09/19
|
UNICHEM |
>>>活性成分:HYDROCHLOROTHIAZIDE; IRBESARTAN; 剂型/给药途径:TABLET;ORAL; 规格:12.5MG;150MG; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 020758 |
002 |
NDA |
AVALIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
Yes |
Yes |
AB |
1997/09/30
|
SANOFI AVENTIS US |
| 077369 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/03/30
|
TEVA |
| 077446 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/09/27
|
SANDOZ |
| 202414 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/09/27
|
MACLEODS PHARMS LTD |
| 203500 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/09/27
|
DR REDDYS LABS LTD |
| 090351 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/10/15
|
HIKMA |
| 091370 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2012/10/15
|
ALEMBIC |
| 203630 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2013/02/22
|
AUROBINDO PHARMA LTD |
| 201524 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Discontinued |
No |
No |
AB |
2013/02/27
|
LUPIN LTD |
| 203072 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2014/05/09
|
PRINSTON INC |
| 207896 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Prescription |
No |
No |
AB |
2016/10/14
|
HISUN PHARM HANGZHOU |
| 207018 |
001 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;150MG |
Discontinued |
No |
No |
AB |
2017/09/19
|
UNICHEM |
>>>活性成分:HYDROCHLOROTHIAZIDE; IRBESARTAN; 剂型/给药途径:TABLET;ORAL; 规格:12.5MG;300MG; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 020758 |
003 |
NDA |
AVALIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
Yes |
Yes |
AB |
1998/08/31
|
SANOFI AVENTIS US |
| 077369 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/03/30
|
TEVA |
| 077446 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/09/27
|
SANDOZ |
| 202414 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/09/27
|
MACLEODS PHARMS LTD |
| 203500 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/09/27
|
DR REDDYS LABS LTD |
| 090351 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/10/15
|
HIKMA |
| 091370 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/10/15
|
ALEMBIC |
| 203630 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2013/02/22
|
AUROBINDO PHARMA LTD |
| 201524 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Discontinued |
No |
No |
AB |
2013/02/27
|
LUPIN LTD |
| 203072 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2014/05/09
|
PRINSTON INC |
| 207896 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2016/10/14
|
HISUN PHARM HANGZHOU |
| 207018 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Discontinued |
No |
No |
AB |
2017/09/19
|
UNICHEM |
>>>活性成分:HYDROCHLOROTHIAZIDE; IRBESARTAN; 剂型/给药途径:TABLET;ORAL; 规格:12.5MG;300MG; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 020758 |
003 |
NDA |
AVALIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
Yes |
Yes |
AB |
1998/08/31
|
SANOFI AVENTIS US |
| 077369 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/03/30
|
TEVA |
| 077446 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/09/27
|
SANDOZ |
| 202414 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/09/27
|
MACLEODS PHARMS LTD |
| 203500 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/09/27
|
DR REDDYS LABS LTD |
| 090351 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/10/15
|
HIKMA |
| 091370 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2012/10/15
|
ALEMBIC |
| 203630 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2013/02/22
|
AUROBINDO PHARMA LTD |
| 201524 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Discontinued |
No |
No |
AB |
2013/02/27
|
LUPIN LTD |
| 203072 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2014/05/09
|
PRINSTON INC |
| 207896 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Prescription |
No |
No |
AB |
2016/10/14
|
HISUN PHARM HANGZHOU |
| 207018 |
002 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
12.5MG;300MG |
Discontinued |
No |
No |
AB |
2017/09/19
|
UNICHEM |
>>>活性成分:HYDROCHLOROTHIAZIDE; IRBESARTAN; 剂型/给药途径:TABLET;ORAL; 规格:25MG;300MG; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 203630 |
003 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
25MG;300MG |
Prescription |
No |
No |
AB |
2016/03/31
|
AUROBINDO PHARMA LTD |
| 091370 |
003 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
25MG;300MG |
Prescription |
No |
No |
AB |
2016/10/12
|
ALEMBIC |
| 090351 |
003 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
25MG;300MG |
Prescription |
No |
No |
AB |
2017/06/08
|
HIKMA |
>>>活性成分:HYDROCHLOROTHIAZIDE; IRBESARTAN; 剂型/给药途径:TABLET;ORAL; 规格:25MG;300MG; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 203630 |
003 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
25MG;300MG |
Prescription |
No |
No |
AB |
2016/03/31
|
AUROBINDO PHARMA LTD |
| 091370 |
003 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
25MG;300MG |
Prescription |
No |
No |
AB |
2016/10/12
|
ALEMBIC |
| 090351 |
003 |
ANDA |
IRBESARTAN AND HYDROCHLOROTHIAZIDE |
HYDROCHLOROTHIAZIDE; IRBESARTAN |
TABLET;ORAL |
25MG;300MG |
Prescription |
No |
No |
AB |
2017/06/08
|
HIKMA |